-
A Phase III International Randomized Controlled Study of Rigosertib Versus Physician's Choice of Treatment in Patients With Myelodysplastic Syndrome ...
The study's primary objective [in a population of patients with MDS after failure of treatment with azacitidine (AZA) or ...
S. Hamid Sayer, Md
-
Phase III Randomized Study of Crenolanib versus Midostaurin Administered Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed Subjects with ...
This is a phase III randomized multi-center study designed to compare the efficacy of crenolanib with that of midostaurin when ...S. Hamid Sayer, Md
Showing - of studies